Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct

Por Turner, Mark A
Publicado no Br J Clin Pharmacol (2015)

Psychosis, agnosia, and confabulation: an alternative two-factor account

Por Turner, Mark A.
Publicado no Cogn Neuropsychiatry (2014)

Intravenous long-lines in children with cystic fibrosis: a multidisciplinary approach.

Por Turner, Mark A, Unsworth, Veda, David, Timothy J
Publicado em 2002

Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey

Por Turner, Mark A, Lewis, Sara, Hawcutt, Daniel B, Field, D
Publicado em 2009

Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uN...

Por Tang, Ai-Wei, Alfirevic, Zarko, Turner, Mark A, Drury, Jo, Quenby, Siobhan
Publicado em 2009

Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients

Por Buckley, Lorrene A., Salunke, Smita, Thompson, Karen, Baer, Gerri, Fegley, Darren, Turner, Mark A.
Publicado no Int J Pharm (2017)

Hospitalised neonates in Estonia commonly receive potentially harmful excipients

Por Lass Jana, Naelapää Kaisa, Shah Utpal, Käär Ruth, Varendi Heili, Turner Mark A, Lutsar Irja
Publicado em 2012-08-01

TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation

Por Ng, Sze M, Turner, Mark A, Gamble, Carrol, Didi, Mohammed, Victor, Suresh, Weindling, Alan M
Publicado em 2008

Hospitalised neonates in Estonia commonly receive potentially harmful excipients

Por Lass, Jana, Naelapää, Kaisa, Shah, Utpal, Käär, Ruth, Varendi, Heili, Turner, Mark A, Lutsar, Irja
Publicado em 2012

Comparison of two alternative study designs in assessment of medicines utilisation in neonates

Por Nellis, Georgi, Lutsar, Irja, Varendi, Heili, Toompere, Karolin, Turner, Mark A, Duncan, Jennifer, Metsvaht, Tuuli
Publicado em 2014

Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey

Por Pansieri, Claudia, Pandolfini, Chiara, Elie, Valery, Turner, Mark A., Kotecha, Sailesh, Jacqz-Aigrain, Evelyne, Bonati, Maurizio
Publicado no Sci Rep (2014)

SCAMP: standardised, concentrated, additional macronutrients, parenteral nutrition in very preterm infants: a phase IV randomised, controlled exploratory study of macronutrient int...

Por Morgan, Colin, Herwitker, Shakeel, Badhawi, Isam, Hart, Anna, Tan, Maw, Mayes, Kelly, Newland, Paul, Turner, Mark A
Publicado em 2011

Wide intra- and inter-country variability in drug use and dosage in very-low-birth-weight newborns with severe infections

Por Pandolfini, Chiara, Kaguelidou, Florentia, Sequi, Marco, Jacqz-Aigrain, Evelyne, Choonara, Imti, Turner, Mark A., Manzoni, Paolo, Bonati, Maurizio
Publicado em 2012

Randomized, Controlled Trial Evaluating a Baby Wash Product on Skin Barrier Function in Healthy, Term Neonates

Por Lavender, Tina, Bedwell, Carol, Roberts, Stephen A, Hart, Anna, Turner, Mark A, Carter, Lesley-Anne, Cork, Michael J
Publicado em 2013

Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents' Experiences of Their Child's Suspected Adverse Drug Reaction

Por Arnott, Janine, Hesselgreaves, Hannah, Nunn, Anthony J., Peak, Matthew, Pirmohamed, Munir, Smyth, Rosalind L., Turner, Mark A., Young, Bridget
Publicado em 2012

What can we learn from parents about enhancing participation in pharmacovigilance?

Por Arnott, Janine, Hesselgreaves, Hannah, Nunn, Anthony J, Peak, Matthew, Pirmohamed, Munir, Smyth, Rosalind L, Turner, Mark A, Young, Bridget
Publicado em 2013

Randomized controlled trials of antibiotics for neonatal infections: a systematic review

Por Kaguelidou, Florentia, Turner, Mark A, Choonara, Imti, van Anker, John, Manzoni, Paolo, Alberti, Corinne, Langhendries, Jean-Paul, Jacqz-Aigrain, Evelyne
Publicado em 2013

Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001–2010: content and utility analysis

Por Hawcutt, Daniel B., Russell, Nicki‐Jayne, Maqsood, Hannah, Kouranloo, Koushan, Gomberg, Simon, Waitt, Catriona, Sharp, Andrew, Riordan, Andrew, Turner, Mark A.
Publicado no Br J Clin Pharmacol (2016)

Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool

Por Bracken, Louise E., Nunn, Anthony J., Kirkham, Jamie J., Peak, Matthew, Arnott, Janine, Smyth, Rosalind L., Pirmohamed, Munir, Turner, Mark A.
Publicado no PLoS One (2017)

Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence

Por Richey, Roberta H, Shah, Utpal U, Peak, Matthew, Craig, Jean V, Ford, James L, Barker, Catrin E, Nunn, Anthony J, Turner, Mark A
Publicado em 2013